Dermira Prices its Initial Public Offering

San Francisco – October 27, 2014 – Cooley advised the underwriters on Dermira, Inc.'s $125 million initial public offering. Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients. The company now trades on The NASDAQ Global Select Market under the symbol "DERM."

Citigroup Global Markets Inc. and Leerink Partners LLC acted as joint book-running managers for the offering, and Guggenheim Securities, LLC and Needham & Company, LLC acted as co-managers for the offering. The underwriters have been granted a 30-day option to purchase up to 1,171,875 additional shares of common stock.

The Cooley corporate and securities team advising the underwriters was comprised of partners Drew Williamson, David Peinsipp and Charlie Kim, and associates Kristin VanderPas, Robert E. Jones and Eric Cheng.

Critical support was provided by partners Natasha Leskovsek and Wendy Goldstein, special counsel Phil Mitchell and associate Jennifer Shanley (health care and life sciences regulatory); partner Bill Christiansen (intellectual property); partner Renee Deming (compensation and benefits); and partner Susan Cooper Philpot (tax).

Thus far in 2014, Cooley has advised on 86 completed public offerings, including 44 completed IPOs.

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.

Cooley has 800 lawyers across 11 offices in the United States and China.

Related Contacts
David Peinsipp  Partner San Francisco, Palo Alto
Charlie Kim  Partner San Diego, Los Angeles – Santa Monica
Bill Christiansen  Partner Seattle
Kristin VanderPas  Partner San Francisco
Drew Williamson  Partner San Francisco
Phil Mitchell  Partner New York